Fresenius Group Overview


DGAP Ad-hoc - Fresenius SE & Co. KGaA: Fresenius raises 2015 earnings guidance

  • Contact

    Markus Georgi

    Senior Vice President Investor Relations
    T: +49 (0) 6172 608-2485

Fresenius SE & Co. KGaA: Fresenius raises 2015 earnings guidance

Fresenius SE & Co. KGaA / Key word(s): Change in Forecast

29.04.2015 22:13

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Fresenius raises 2015 earnings guidance

Based on positive business prospects, Fresenius raises its earnings
guidance for 2015.

Fresenius now expects net income* growth of 13% to 16% in constant
currency. Previously, the company expected net income* growth of 9% to 12%
in constant currency. The company fully confirms its Group sales guidance.
Sales are expected to increase by 7% to 10% in constant currency.

In the United States, Fresenius Kabi exceeded our expectations in the first
months of 2015. Due to significantly improved prospects in the U.S.,
Fresenius Kabi raises its outlook for 2015. For 2015, Fresenius Kabi now
expects organic sales growth of 4% to 7%. EBIT growth in constant currency
is expected to be in the range of 11% to 14%. Previously, Fresenius Kabi
projected organic sales growth of 3% to 5% and an EBIT growth in constant
currency in the range of 4% to 6%.

* Net income attributable to shareholders of Fresenius SE & Co. KGaA; 2015
before integration costs (~EUR10 million before tax for hospitals acquired
from Rhön-Klinikum AG), before costs for the efficiency program at
Fresenius Kabi (~EUR100 million before tax), and before the disposal gain
from the divestment of two HELIOS hospitals (EUR34 million before tax);
2014 before special items

(Financial statements according to U.S. GAAP)

Fresenius SE & Co. KGaA,
represented by Fresenius Management SE,
Board of Management

Bad Homburg v.d.H., April 29, 2015

End of note

29.04.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at and


Language: English
Company: Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Phone: +49 (0)6172 608-2485
Fax: +49 (0)6172 608-2488
ISIN: DE0005785604
WKN: 578560
Indices: DAX
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard),
Munich; Regulated Unofficial Market in Berlin, Hamburg,
Hanover, Stuttgart; Terminbörse EUREX

End of Announcement DGAP News-Service